(Table 5) For late-phase disease-free survival, tumor size (P = .076) and albumin (P = .056) showed potential predictabilities and were included in multivariate analysis with CD3+ (P = .014) and CD8+ (P = .035) cells. Here, CD8A is linked to neoplasm.